EP0749319A4 - Immortalized cells and uses therefor - Google Patents

Immortalized cells and uses therefor

Info

Publication number
EP0749319A4
EP0749319A4 EP19930920511 EP93920511A EP0749319A4 EP 0749319 A4 EP0749319 A4 EP 0749319A4 EP 19930920511 EP19930920511 EP 19930920511 EP 93920511 A EP93920511 A EP 93920511A EP 0749319 A4 EP0749319 A4 EP 0749319A4
Authority
EP
European Patent Office
Prior art keywords
immortalized cells
uses therefor
therefor
immortalized
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19930920511
Other languages
German (de)
French (fr)
Other versions
EP0749319A1 (en
Inventor
Timothy J Miller
Stephen K Wikel
Rangappa N Ramachandra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma State University
Pfizer Inc
Original Assignee
Oklahoma State University
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma State University, Pfizer Inc filed Critical Oklahoma State University
Publication of EP0749319A4 publication Critical patent/EP0749319A4/en
Publication of EP0749319A1 publication Critical patent/EP0749319A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP93920511A 1992-09-14 1993-09-14 Immortalized cells and uses therefor Withdrawn EP0749319A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94487392A 1992-09-14 1992-09-14
PCT/US1993/008606 WO1994006463A1 (en) 1992-09-14 1993-09-14 Immortalized cells and uses therefor
US944873 2001-08-31

Publications (2)

Publication Number Publication Date
EP0749319A4 true EP0749319A4 (en) 1996-09-16
EP0749319A1 EP0749319A1 (en) 1996-12-27

Family

ID=25482205

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93920511A Withdrawn EP0749319A1 (en) 1992-09-14 1993-09-14 Immortalized cells and uses therefor

Country Status (5)

Country Link
EP (1) EP0749319A1 (en)
JP (1) JPH08502646A (en)
AU (2) AU5103293A (en)
CA (1) CA2144651A1 (en)
WO (1) WO1994006463A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989866A (en) 1996-10-16 1999-11-23 Zymogenetics, Inc. FGF homologs
US6017757A (en) * 1997-02-20 2000-01-25 Mississippi State University Isolated viable nematode intestinal cells
IL142164A0 (en) 1998-09-23 2002-03-10 Zymogenetics Inc Cytokine receptor zalpha11
JP4739526B2 (en) 1998-12-07 2011-08-03 ザイモジェネティクス， インコーポレイテッド Growth factor homolog zvegf3
CA2753331A1 (en) 1999-01-07 2000-07-13 Zymogenetics, Inc. Soluble receptor br43x2 and methods of using
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
ATE377076T1 (en) 1999-03-09 2007-11-15 Zymogenetics Inc HUMAN CYTOKINE AS A LIGAND OF THE ZALPHA RECEPTOR AND ITS USES
ATE459716T1 (en) 1999-12-23 2010-03-15 Zymogenetics Inc CYTOKINE ZCYT018
AU2001273032A1 (en) 2000-06-26 2002-01-08 Zymogenetics Inc. Cytokine receptor zcytor17
AU2002336676A1 (en) 2001-11-05 2003-05-19 Zymogenetics, Inc Il-21 antagonists
WO2004003140A2 (en) 2002-01-18 2004-01-08 Zymogenetics, Inc. Cytokine receptor zcytor17 multimers
PT2230299E (en) 2002-01-18 2012-03-02 Zymogenetics Inc Novel cytokine zcytor17 ligand
RU2004133765A (en) 2002-04-19 2005-06-27 ЗАЙМОДЖЕНЕТИКС Инк. (US) CYTOKINE RECEPTOR
ES2405209T3 (en) 2003-08-07 2013-05-30 Zymogenetics, Inc. Homogeneous preparations of lL-29
CA2558811A1 (en) 2004-03-08 2005-09-22 Zymogenetics, Inc. Dimeric fusion proteins and materials and methods for producing them
EP1793845A2 (en) 2004-07-29 2007-06-13 ZymoGenetics, Inc. Use of il-28 and il-29 to treat cancer
MX2008001661A (en) 2005-08-09 2008-04-07 Ares Trading Sa Methods for treating b-cell malignancies using taci-ig fusion molecule.
JP5118037B2 (en) 2005-08-09 2013-01-16 ザイモジェネティクス， インコーポレイテッド Methods for the treatment and prevention of abnormal cell proliferation using TACI fusion molecules
CA2651791A1 (en) 2006-05-15 2007-11-22 Ares-Trading S.A. Methods for treating autoimmune diseases using a taci-ig fusion molecule
US7754689B2 (en) 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
WO2007143161A2 (en) 2006-06-02 2007-12-13 Wyeth Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
MX2009004866A (en) 2006-11-03 2009-05-19 Schering Plough Ltd Canine lyme disease vaccine.
US20100240597A1 (en) 2007-06-15 2010-09-23 Arkansas State University Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
DK2274008T3 (en) 2008-03-27 2014-05-12 Zymogenetics Inc Compositions and Methods for Inhibition of PDGFRBETA and VEGF-A
CN102131517B (en) 2008-06-27 2014-12-17 津莫吉尼蒂克斯公司 Soluble hybrid fc gamma receptors and related methods
EA022932B1 (en) 2010-06-09 2016-03-31 Зимодженетикс, Инк. Dimeric vstm3 fusion proteins and related compositions and methods
DK2809795T3 (en) 2012-02-01 2019-12-16 Sgi Dna Inc MATERIALS AND PROCEDURES FOR SYNTHESIS OF ERROR-MINIMIZED NUCLEIC ACID MOLECULES
JP6953020B2 (en) 2015-09-08 2021-10-27 セリピオン， インコーポレイテッド ApoA-1 fusion polypeptide and related compositions and methods
WO2018136163A2 (en) 2016-12-09 2018-07-26 Theripion, Inc. Tandem apoa-1 fusion polypeptides
IL272103B1 (en) 2017-07-20 2024-06-01 Aptevo Res & Development Llc Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods of treating cancer
DK3710484T3 (en) 2017-12-20 2023-11-27 Harbour Biomed Shanghai Co Ltd CTLA-4 BINDING ANTIBODIES AND USES THEREOF
US10150801B1 (en) 2017-12-27 2018-12-11 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
WO2019132765A1 (en) 2017-12-27 2019-07-04 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
US10675332B1 (en) 2019-08-26 2020-06-09 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
EP4021512A1 (en) 2019-08-26 2022-07-06 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and methods of use thereof
EP4168034A1 (en) 2020-06-22 2023-04-26 Imunami Laboratories Pte. Ltd. Recombinant polypeptides and combinations for use in the treatment of cancer
CA3206901A1 (en) 2021-02-19 2022-08-25 Theripion, Inc. Paraoxonase fusion polypeptides and related compositions and methods
WO2024148328A2 (en) 2023-01-06 2024-07-11 Aptevo Research And Development Llc Bispecific pd-l1 and cd40 binding molecules and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003929A1 (en) * 1986-11-27 1988-06-02 Biotechnology Australia Pty. Ltd. Vaccine containing tick antigens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447537A (en) * 1981-01-22 1984-05-08 The United States Of Americas As Represented By The Department Of Health And Human Services Tick cell lines
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003929A1 (en) * 1986-11-27 1988-06-02 Biotechnology Australia Pty. Ltd. Vaccine containing tick antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9406463A1 *

Also Published As

Publication number Publication date
EP0749319A1 (en) 1996-12-27
AU5103293A (en) 1994-04-12
AU4831497A (en) 1998-03-26
CA2144651A1 (en) 1994-03-31
WO1994006463A1 (en) 1994-03-31
JPH08502646A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
EP0749319A4 (en) Immortalized cells and uses therefor
GB2270195B (en) Electrochemical cell
TW441662U (en) Cell material structure
ZA928933B (en) Load cell
EP0347549A3 (en) Sealing member and roll therefor
GB2281655B (en) Electrochemical cell
GB2280779B (en) Electrochemical cell
EP0732396A4 (en) Microorganism and deodorant containing cells thereof
GB2281436B (en) Electrochemical cell
GB2281830B (en) I/q-modulator and i/q-demodulator
GB2276759B (en) Electrochemical cell
GB2270794B (en) Electrochemical cell
GB9215710D0 (en) Analysis of cells
IL102374A0 (en) Nanocrystalline cell
GB9216654D0 (en) Transformed cells and assays using them
GB9216393D0 (en) Electrochemical cell
AU2640595A (en) Immortalized and transformed astrocyte-derived cells
GB2269265B (en) Electrochemical cell
AU2278797A (en) Drywell cover and drywell
GB9220655D0 (en) Load cell
GB2271667B (en) Battery cell
GB9207276D0 (en) Modified cells
GB9213256D0 (en) Cell
GB9321937D0 (en) Cultured cells
GB9016031D0 (en) Cell lysis

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950711

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 19981002

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990213